equityflowunderstand the flow and follow it
EquityFlowCompanies › Solu

Solu

Biotech · Helsinki, FI

Builds a pathogen DNA database to combat antibiotic resistance

In the network

Shares the most investors with (number = shared investors):

Funding history

DateRoundAmount
Jun 2023Seed
Helsinki biotech Solu raised EUR1M seed to build a pathogen DNA library against antibiotic resistance.
$1.1M

Investors

Tap an investor to see what else they have backed.

Other companies in Biotech

Other companies in FI

Other companies at Seed stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.